Artículos Científicos en Ingles

Artículos Científicos RSS AJKD

G-492 OBSERVE-GN: Obinutuzumab Safety and Effectiveness in Real-world eValuation of Glomerular Nephropathies

Este artículo no posee resumen

G-491 Health Outcome Disparities and Determinants of Progression in a Multiethnic Cohort of IgAN Patients

Este artículo no posee resumen

G-490 COMBO-IGNITE: Real-World Effectiveness and Early Safety Signals of Combination Therapy in IgA Nephropathy

Este artículo no posee resumen

G-489 DNAJB9-Positive Crescentic Fibrillary Glomerulonephritis With Full-House IF: Dialysis-Dependent AKI and Patient-Directed Deferral of Cyclophosphamide

Este artículo no posee resumen

G-488 Impact of SGLT2i Use on Sibeprenlimab Outcomes in IgA Nephropathy (IgAN): Subgroup Analysis From the Phase 3 VISIONARY Trial Interim Analysis

Este artículo no posee resumen

G-487 Sibeprenlimab in IgA Nephropathy: Assessment of Target Proteinuria Thresholds in the Phase 3 VISIONARY Trial Interim Analysis

Este artículo no posee resumen

G-475 A Case of De Novo Crescentic IgA Nephropathy Triggered by Polytrauma

Este artículo no posee resumen

G-474 A Rare Case of Crescentic IgA Nephropathy in a Transplant Kidney Leading to Graft Dysfunction

Este artículo no posee resumen

G-462 Bridging the Therapeutic Gap: Impact of Online Continuing Medical Education on Nephrologist Readiness for Emerging B-Cell Therapies in IgA Nephropathy

Este artículo no posee resumen

G-461 Continuing Medical Education Enhances Clinical Readiness for Emerging B-Cell Therapies in IgA Nephropathy Among Nephrologists and Nurses

Este artículo no posee resumen

G-460 Case of Enterococcus Endocarditis Masquerading as Vasculitis - A Diagnostic Dilemma:

Este artículo no posee resumen

G-459 Crescentic Fibrillary Glomerulonephritis: A Case Report

Este artículo no posee resumen

G-458 Clinicopathologic Features and Prognostic Factors in Biopsy-Confirmed Renal Involvement in Primary Sjögren’s Syndrome

Este artículo no posee resumen

G-457 What Treatment Factors Matter Most to Patients With IgA Nephropathy? Insights From a Multicountry Discrete Choice Experiment

Este artículo no posee resumen

G-456 Proteinuria Reductions With Sparsentan (SPAR) Combined With Sodium-Glucose Cotransporter-2 Inhibitors (SGLT2is) in Adults With IgA Nephropathy (IgAN): A Single-Site Case Series

Este artículo no posee resumen

Páginas